N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients

It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Xiaofen, Hu, Maolin, Li, Zongchang, Cao, Hongbao, He, Ying, Liao, Yanhui, Zhou, Jun, Sang, Deen, Zhao, Hongzeng, Tang, Jinsong, Lv, Luxian, Chen, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894446/
https://www.ncbi.nlm.nih.gov/pubmed/25778460
http://dx.doi.org/10.1038/srep09109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894446/
https://www.ncbi.nlm.nih.gov/pubmed/25778460
http://dx.doi.org/10.1038/srep09109

Ejemplares similares